about
Robert K. Crane-Na(+)-glucose cotransporter to cure?First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitusIndirect homologous competitive enzyme-linked immunosorbent assay for the detection of a class of glycosylated dihydrochalconesDapagliflozin for type 2 diabetes mellitusThe SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside ReviewThioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetesInsulin use early in the course of type 2 diabetes mellitus: the ORIGIN trialRenal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of actionSodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effectsSodium-Glucose Cotransporter 2 (SGLT2) Inhibitors from Natural Products: Discovery of Next-Generation Antihyperglycemic AgentsGenetic origins of lactase persistence and the spread of pastoralism in AfricaExpansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2Glucose transport into everted sacs of the small intestine of miceMouse SGLT3a generates proton-activated currents but does not transport sugarFunctional characterization of mouse sodium/glucose transporter type 3bA drug delivery strategy: binding enkephalin to asialoglycoprotein receptor by enzymatic galactosylationFatty acid esters of phloridzin induce apoptosis of human liver cancer cells through altered gene expressionSynergistic Malaria Parasite Killing by Two Types of Plasmodial Surface Anion Channel InhibitorsEffect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal modelsDifferential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistanceHuman genetics as a model for target validation: finding new therapies for diabetes.Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?Sodium-glucose transporter-2 (SGLT2; SLC5A2) enhances cellular uptake of aminoglycosides.Sodium-Glucose linked transporter 2 (SGLT2) inhibitors--fighting diabetes from a new perspective.Canagliflozin-current status in the treatment of type 2 diabetes mellitus with focus on clinical trial data.Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.A fluorescence method for measurement of glucose transport in kidney cellsSGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathyThe use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease.Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.The transport mechanism of the human sodium/myo-inositol transporter 2 (SMIT2/SGLT6), a member of the LeuT structural family.A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor.A Review on the Relationship between SGLT2 Inhibitors and Cancer.Update on developments with SGLT2 inhibitors in the management of type 2 diabetesCardiovascular impact of drugs used in the treatment of diabetesAcute anti-hyperglycaemic effects of an unripe apple preparation containing phlorizin in healthy volunteers: a preliminary study.The Sweet Pee model for Sglt2 mutationEmpagliflozin in the treatment of type 2 diabetes: evidence to dateRegulation of endogenous glucose production in glucose transporter 4 over-expressing mice.Dapagliflozin for the treatment of type 2 diabetes: a review of the literature
P2860
Q21129244-783D1DDE-0A3E-44B7-B96A-6B2FC9D2A732Q21195757-EC7B8B37-24C6-46E7-8AC7-8B6FCD45CF2DQ23910070-09602B7C-5578-4169-BA16-F793D0E10E82Q24234557-53622E51-3CA2-447E-A3FE-BEBBCA069C3AQ24563917-42FE4BC4-D9D5-45CF-9A12-F924E3229CD4Q24684670-0133166F-A246-4CED-9D35-501DE3F405BCQ27024597-1101DE89-CF69-45EE-BF32-F7592A4C8153Q27027105-80FD0862-8DC2-4C4C-8AF3-366DEE7EC0C6Q28072765-CBDBC1E0-3E9E-457A-976A-A68804F3FE2CQ28074843-58B1191C-CFA1-47D7-8766-62FB34AE5401Q28235932-3E172281-9AB6-4719-8647-BB49E9F772EAQ28288604-12BB6F51-B306-463C-9BBF-EB6842137124Q28303103-25F48F66-493D-4302-AE1E-96F569CE7299Q28508825-A8EA6694-EC65-4985-9B46-1DDEFDAA567EQ28511559-B19140FB-7BF8-4A7D-BEF2-A5D352B1E4A9Q28537923-6E6B5288-A7D1-4AD2-B927-7EAC876E36F8Q28543028-D88F920B-F75D-44C4-A624-CB05E3F08AAFQ28550091-27033630-7275-493D-A36F-182E85B3F37CQ28732080-0E4338F3-8AE8-48AA-97EA-B0576E24682AQ28743462-6D5AA04A-E619-46E4-A07C-9EFE7E62A24CQ30234640-1EE57C35-0590-4B2D-A05B-EC4ABAB7011AQ30426407-2C2B9232-213F-4708-A2B2-B9C740E6CCC0Q30429061-00C85937-E7A3-45BB-A9DD-3437C8FCA9A9Q30833760-712C19E3-AD78-4D92-814F-8E7B9897D570Q33759610-64DF8102-F5FC-4FBB-AD1A-F3CD1FE85DC9Q33837017-8CFA1850-7A15-4DEA-962D-320435E2814EQ33878898-CDFA3E53-B0F7-468C-89E5-CF91E5295AA4Q34101200-4B7579C7-96C9-46A2-9E87-70DF53F30D27Q34118975-9C268EF2-2684-40EF-8ED0-6C75121F4294Q34120717-D1EDBF1F-6C2A-4B8C-94F0-21F79B9A7589Q34130870-9A271E8D-C88B-4FD0-B881-C26B7A4D01D0Q34161881-A1F404E9-E0C6-4B1B-B1B1-1E2A3B784A8BQ34181385-D26DF12B-303F-42A6-B830-847633871818Q34198692-C56E728B-10F2-478B-A0C1-70F022736823Q34383575-715072BA-8ED0-4BF7-A445-3455412B010DQ34424092-F7CBC27D-CD8F-4780-8A85-6530732D37A9Q34457273-415F1768-A6FD-4F75-AAFF-FE6CF59DBCC9Q34502358-072B4F08-C1C1-4417-B488-B717AA727D60Q34533692-F69130F2-BE39-4688-8141-540C47321277Q34710819-451FF89D-6E5B-4EB1-919E-7737492A59BC
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Phlorizin: a review.
@ast
Phlorizin: a review.
@en
type
label
Phlorizin: a review.
@ast
Phlorizin: a review.
@en
prefLabel
Phlorizin: a review.
@ast
Phlorizin: a review.
@en
P2093
P356
P1476
Phlorizin: a review.
@en
P2093
Jesse Roth
Joel R L Ehrenkranz
Norman G Lewis
P356
10.1002/DMRR.532
P577
2005-01-01T00:00:00Z